SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-19-047282
Filing Date
2019-08-26
Accepted
2019-08-26 16:15:34
Documents
1
Period of Report
2019-07-15

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 4853
  Complete submission text file 0001104659-19-047282.txt   6203
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address
Wedell-Wedellsborg Johan (Reporting) CIK: 0001753185 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38650 | Film No.: 191053086